Clinical Trial Update: Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project

View source ↗

Summary

This clinical trial update describes the PRO SID Project, which aims to develop and validate a patient-reported outcome screening measure for infections and qua…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Immunodeficiency
• Multiple Myeloma

Snippet

Sponsor: Medical University Innsbruck | Conditions: Chronic Lymphocytic Leukaemia (CLL), Multiple Myeloma (MM) | Status: RECRUITING